Detalles de la búsqueda
1.
Thymic Innervation Impairment in Experimental Autoimmune Encephalomyelitis.
Neuroimmunomodulation
; 31(1): 25-39, 2024.
Artículo
Inglés
| MEDLINE | ID: mdl-38128499
2.
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis.
Int J Mol Sci
; 24(9)2023 Apr 28.
Artículo
Inglés
| MEDLINE | ID: mdl-37175706
3.
Partial remission in Brazilian children and adolescents with type 1 diabetes. Association with a haplotype of class II human leukocyte antigen and synthesis of autoantibodies.
Pediatr Diabetes
; 21(4): 606-614, 2020 06.
Artículo
Inglés
| MEDLINE | ID: mdl-32078220
4.
Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
Infect Immun
; 83(10): 3781-92, 2015 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-26169268
5.
Ten years of proteomics in multiple sclerosis.
Proteomics
; 14(4-5): 467-80, 2014 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-24339438
6.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Mult Scler
; 20(9): 1189-97, 2014 08.
Artículo
Inglés
| MEDLINE | ID: mdl-24477120
7.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Proteomics
; 12(17): 2656-62, 2012 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-22740327
8.
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients.
Mult Scler
; 18(7): 1038-41, 2012 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-22041091
9.
Quantitative MRI and cerebrospinal fluid inflammatory mediators in Brazilian patients with relapsing-remitting multiple sclerosis before and after treatment with immunomodulators: a longitudinal study.
Neuroimmunomodulation
; 19(5): 277-82, 2012.
Artículo
Inglés
| MEDLINE | ID: mdl-22472803
10.
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: a randomized study.
BMC Complement Altern Med
; 12: 209, 2012 Nov 05.
Artículo
Inglés
| MEDLINE | ID: mdl-23126260
11.
Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients.
Front Immunol
; 13: 750660, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-35197967
12.
Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse.
J Neuroinflammation
; 8(1): 2, 2011 Jan 07.
Artículo
Inglés
| MEDLINE | ID: mdl-21214939
13.
Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubes.
Nanotechnology
; 22(26): 265103, 2011 Jul 01.
Artículo
Inglés
| MEDLINE | ID: mdl-21576788
14.
Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis.
Mult Scler Relat Disord
; 52: 103013, 2021 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-34030100
15.
Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis.
Seizure
; 90: 117-122, 2021 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-33658153
16.
Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients - Brief Research Report.
Front Cell Neurosci
; 15: 705618, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-34381335
17.
Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
Neuroimmunomodulation
; 17(1): 56-66, 2010.
Artículo
Inglés
| MEDLINE | ID: mdl-19816058
18.
Massive activity of cytotoxic cells during refractory Neuromyelitis Optica spectrum disorder.
J Neuroimmunol
; 340: 577148, 2020 03 15.
Artículo
Inglés
| MEDLINE | ID: mdl-31986375
19.
Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens.
Neuroimmunomodulation
; 16(1): 54-62, 2009 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-19077446
20.
From Charcot's descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosis.
Arq Neuropsiquiatr
; 77(7): 521-524, 2019 07 29.
Artículo
Inglés
| MEDLINE | ID: mdl-31365644